Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Thomas K Eigentler
Clinical Validation of a Prognostic 11-Gene Expression Profiling Score in Prospectively Collected FFPE Tissue of Patients With AJCC V8 Stage II Cutaneous Melanoma
European Journal of Cancer
Cancer Research
Oncology
Tolerability of BRAF/MEK Inhibitor Combinations: Adverse Event Evaluation and Management
ESMO Open
Cancer Research
Oncology
Related publications
Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma
Clinical Cancer Research
Cancer Research
Oncology
Prognostic Significance of Tissue Proteomic Profiling in Stage I and II Cutaneous Malignant Melanoma of the Head and Neck
Prognostic Impact of Mutation Profiling in Patients With Stage II and III Colon Cancer
Scientific Reports
Multidisciplinary
Prognostic Impact of P62 Expression in Cutaneous Malignant Melanoma
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Use of a Prognostic Gene Expression Profile Test for T1 Cutaneous Melanoma: Will It Help or Harm Patients?
Journal of the American Academy of Dermatology
Dermatology
Validation of the AJCC Prognostic Stage for HER2-positive Breast Cancer in the ShortHER Trial
BMC Medicine
Medicine
A Gene-Expression Profiling Score for Prediction of Outcome in Patients With Follicular Lymphoma: A Retrospective Training and Validation Analysis in Three International Cohorts
The Lancet Oncology
Oncology
Reply to “Use of a Prognostic Gene Expression Profile Test for T1 Cutaneous Melanoma: Will It Help or Harm Patients?”
Journal of the American Academy of Dermatology
Dermatology
841 Clinical Experience With a Next-Generation Sequencing (NGS) Test for BRAF and NRAS Mutations Along With Gene Expression Profiling (GEP) in Cutaneous Melanoma (CM)
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
